BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8989834)

  • 1. Selective inhibition of receptor-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury.
    Mclntyre RC; Sheridan B; Agrafojo J; Fullerton DA
    Shock; 1997 Jan; 7(1):36-41. PubMed ID: 8989834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxin differentially impairs receptor-mediated relaxation in rat isolated pulmonary and thoracic aortic vessels.
    McIntyre RC; Pulido EJ; Sheridan B; Meldrum DR; Bensard DD; Fullerton DA
    J Trauma; 1998 Nov; 45(5):862-7. PubMed ID: 9820693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vascular smooth muscle relaxation by cAMP-mediated pathways.
    Fullerton DA; Agrafojo J; McIntyre RC
    J Surg Res; 1996 Mar; 61(2):444-8. PubMed ID: 8656622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KATP channels contribute to beta- and adenosine receptor-mediated pulmonary vasorelaxation.
    Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
    Am J Physiol; 1997 Nov; 273(5):L950-6. PubMed ID: 9374721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury.
    Fullerton DA; McIntyre RC; Hahn AR; Agrafojo J; Koike K; Meng X; Banerjee A; Harken AH
    Am J Physiol; 1995 Jun; 268(6 Pt 1):L1029-35. PubMed ID: 7611425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation.
    Pulido EJ; Shames BD; Selzman CH; Barton HA; Banerjee A; Bensard DD; McIntyre RC
    Am J Physiol; 1999 Oct; 277(4):L769-76. PubMed ID: 10516218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A1-receptor mechanisms antagonize beta-adrenergic pulmonary vasodilation in hypoxia.
    McIntyre RC; Banerjee A; Bensard DD; Brew EC; Hahn AR; Fullerton DA
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2179-85. PubMed ID: 7810717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin differentially impairs cyclic guanosine monophosphate-mediated relaxation in the pulmonary and systemic circulations.
    McIntyre RC; Sheridan B; Agrafojo J; Fullerton DA
    Crit Care Med; 1997 Feb; 25(2):318-23. PubMed ID: 9034271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin stuns cGMP-mediated pulmonary vasorelaxation.
    Sheridan BC; McIntyre RC; Meldrum DR; Meng X; Fullerton DA
    Shock; 1997 Sep; 8(3):207-12. PubMed ID: 9377168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-arginine attenuates endothelial dysfunction in endotoxin-induced lung injury.
    Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
    Surgery; 1999 Jan; 125(1):33-40. PubMed ID: 9889795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension in acute lung injury is due to impaired vasodilation with intact vascular contractility.
    McIntyre RC; Banerjee A; Agrafojo J; Fullerton DA
    J Surg Res; 1995 Jun; 58(6):765-70. PubMed ID: 7791358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotrophin-1 attenuates endotoxin-induced acute lung injury.
    Pulido EJ; Shames BD; Pennica D; O'leary RM; Bensard DD; Cain BS; McIntyre RC
    J Surg Res; 1999 Jun; 84(2):240-6. PubMed ID: 10357926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils mediate pulmonary vasomotor dysfunction in endotoxin-induced acute lung injury.
    Sheridan BC; McIntyre RC; Moore EE; Meldrum DR; Agrafojo J; Fullerton DA
    J Trauma; 1997 Mar; 42(3):391-6; discussion 396-7. PubMed ID: 9095105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-arginine prevents lung neutrophil accumulation and preserves pulmonary endothelial function after endotoxin.
    Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
    Am J Physiol; 1998 Mar; 274(3):L337-42. PubMed ID: 9530168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil depletion attenuates endotoxin-induced dysfunction of cGMP-mediated pulmonary vasorelaxation.
    Sheridan BC; McIntyre RC; Agrafojo J; Meldrum DR; Meng X; Fullerton DA
    Am J Physiol; 1996 Nov; 271(5 Pt 1):L820-8. PubMed ID: 8944726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of endothelial-dependent pulmonary vasorelaxation after mesenteric ischemia/reperfusion.
    Fullerton DA; Eisenach JH; Friese RS; Agrafojo J; Sheridan BC; McIntyre RC
    Surgery; 1996 Nov; 120(5):879-84. PubMed ID: 8909525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of cyclic adenosine monophosphate-mediated pulmonary vasodilation by acute hypoxia.
    McIntyre RC; Banerjee A; Hahn AR; Agrafojo J; Fullerton DA
    Surgery; 1995 Mar; 117(3):314-8. PubMed ID: 7878538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline treatment attenuates pulmonary vasomotor dysfunction in acute lung injury.
    Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
    J Surg Res; 1997 Aug; 71(2):150-4. PubMed ID: 9299283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A1 and A2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung.
    Heller AR; Rothermel J; Weigand MA; Plaschke K; Schmeck J; Wendel M; Bardenheuer HJ; Koch T
    Eur J Anaesthesiol; 2007 Mar; 24(3):258-66. PubMed ID: 17094869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase inhibition overcomes pulmonary vasomotor dysfunction in acute lung injury.
    Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
    J Surg Res; 1997 Aug; 71(2):145-9. PubMed ID: 9299282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.